回盛生物(300871.SZ)：拟投资建设兽用原料药绿色设备技改项目

Core Viewpoint - The company, Huibei Huisheng Biological Technology Co., Ltd., a wholly-owned subsidiary of Huisheng Biological (300871.SZ), has approved an investment of 170 million yuan for the upgrade of its veterinary raw material drug production line through a green equipment technology transformation project [1] Investment Project Summary - The project will be executed in two phases, focusing on upgrading the existing technology and equipment of the veterinary raw material drug production line [1] - The funding for the project will be sourced from the company's own funds [1] Technical Enhancements - The project aims to enhance technology and optimize the composition of production line equipment, introducing new and updated high-efficiency, energy-saving, and highly automated equipment [1] - The upgrade will increase the production capacity of existing raw material drug varieties and add new production lines for fermentation products [1] - The project will also focus on reducing and resourcefully utilizing fermentation waste, as well as upgrading energy-saving measures in systems such as energy storage, air compression, stirring, and wastewater treatment [1] Production Efficiency - The optimization of the production line equipment composition will ensure that the capacity of upstream and downstream equipment is matched, maximizing production line capacity while reducing energy consumption and lowering labor and maintenance costs [1]